GlassScriptPhysician profile
Michael Witthaus
NPI 1871987180
$9,285.58
in general payments reported to CMS, 2019-2025
37 companies · $3,988 in 2025
The $3,988 reported for 2025 was more than what 89% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $479 · 2021: $122 · 2022: $761 · 2023: $1,725 · 2024: $2,212 · 2025: $3,988.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,924 · Grant: $2,000.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,924.49 |
| Grant | $2,000.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $3,189.16 | 2022-2025 | General - Erectile Dysfunction, Ams 700, Ams 800 Artificial Urinary Sphincter |
| Coloplast Corp | $1,665.02 | 2020-2025 | Titan, Speedicath |
| Teleflex LLC | $360.88 | 2021-2024 | Urolift |
| Endo USA, INC. | $360.05 | 2024-2025 | Xiaflex, Aveed, Edex |
| Bayer Healthcare Pharmaceuticals INC. | $347.59 | 2023-2025 | |
| Progenics Pharmaceuticals, INC. | $343.23 | 2022-2025 | Pylarify |
| Abbvie INC. | $312.89 | 2023-2025 | Botox |
| Sumitomo Pharma America, INC. | $285.93 | 2023-2025 | Gemtesa, Orgovyx |
| Laborie Medical Technologies Corp. | $239.92 | 2023-2025 | Optilume Bph Drug Coated Balloon Catheter |
| Endo Pharmaceuticals INC. | $182.31 | 2022-2024 | Xiaflex, Aveed, Edex |
| Tolmar, INC. | $178.25 | 2023-2025 | Jatenzo, Eligard |
| Antares Pharma, INC. | $161.29 | 2024-2025 | Xyosted |
| Tempus Ai, INC | $158.56 | 2024-2025 | Xt Cdx |
| Medtronic, INC. | $148.49 | 2023-2025 | Interstim |
| Astellas Pharma US INC | $144.84 | 2023-2025 | Myrbetriq, Xtandi |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $135.72 | 2023-2025 | Erleada, Akeega |
| Merck Sharp & Dohme LLC | $126.24 | 2022-2025 | Keytruda, Lynparza, Welireg |
| Axonics, INC. | $112.72 | 2022-2024 | Axonics |
| Rigicon,INC. | $100.28 | 2025 | Rigi10 |
| Caldera Medical, INC | $95.72 | 2025 | |
| Urogen Pharma, INC. | $68.34 | 2025 | |
| Integra Lifesciences Corporation | $64.36 | 2022 | |
| Lantheus Medical Imaging, INC. | $54.53 | 2024 | |
| Pfizer INC. | $51.66 | 2025 | |
| Valencia Technologies Corporation | $46.27 | 2025 | Ecoin Device Kit |
| Telix Pharmaceuticals | $45.70 | 2024 | Illuccix |
| Olympus America INC. | $44.57 | 2023-2024 | Itind System, Cysto-Nephro Videoscope |
| Myriad Genetic Laboratories, INC. | $42.29 | 2022-2023 | Prolaris |
| Ferring Pharmaceuticals INC. | $35.87 | 2024-2025 | Adstiladrin |
| Immunitybio, INC. | $33.92 | 2025 | |
| 180 Medical, INC. | $26.17 | 2022-2024 | |
| Astrazeneca Pharmaceuticals LP | $25.92 | 2025 | Lynparza |
| Bioprotect Medical, INC. | $25.66 | 2025 | Bioprotect Balloon Implant System |
| Photocure INC | $20.59 | 2024 | Cysview |
| Accord Healthcare, INC. | $18.01 | 2023 | |
| Amgen INC. | $16.63 | 2023 | Prolia |
| Cook Medical LLC | $16.00 | 2024 | Cook |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Witthaus listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.